PYPL
56
-6
AMAT
46
3
BLK
72
2
IR
68
-3
DGX
39
-9
ZTS
47
-2
TEL
69
-5
DFS
64
-3
NWL
50
-6
PCG
94
-5
R
75
-2
DAL
88
-2
XYL
39
-2
GS
69
-6
COP
59
2
APD
54
2
CI
48
-4
GD
46
-13
GT
60
-2
SYK
71
-2
PYPL
56
-6
AMAT
46
3
BLK
72
2
IR
68
-3
DGX
39
-9
ZTS
47
-2
TEL
69
-5
DFS
64
-3
NWL
50
-6
PCG
94
-5
R
75
-2
DAL
88
-2
XYL
39
-2
GS
69
-6
COP
59
2
APD
54
2
CI
48
-4
GD
46
-13
GT
60
-2
SYK
71
-2
Financhill
Back

Skye Bioscience 10K Form

Buy
53

SKYE
Skye Bioscience

Last Price:
4.70
Seasonality Move:
74.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SKYE News And Ratings

See the #1 stock for the next 7 days that we like better than SKYE

SKYE Financial Statistics

Sales & Book Value

Annual Sales: $339.93K
Cash Flow: $-6.78M
Price / Cash Flow: 0
Annual Sales: $2.50
Price / Book: 2.21

Profitability

EPS (TTM): -0.83790
Net Income (TTM): $-21.24M
Gross Margin: $208.59K
Return on Equity: 0%
Return on Assets: 0%

Skye Bioscience Earnings Forecast

Key Skye Bioscience Financial Ratios

  • The Gross Profit Margin over the past 2 years for SKYE is 61.36%.
  • The Selling, General & Administrative Expenses for SKYE have been equal to 43.69% of Gross Profit Margin.
  • The Interest Expense is -2.38% of Operating Income.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

Skye Bioscience Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SKYE
Website: skyebioscience.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SKYE Technical Analysis vs Fundamental Analysis

Buy
53
Skye Bioscience (SKYE) is a Buy

Is Skye Bioscience a Buy or a Sell?

  • Skye Bioscience stock is rated a Buy
    The current Skye Bioscience [SKYE] share price is $5.51. The Score for SKYE is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.